Human Growth Hormone Drugs Market Size Status and Forecast 2025
Posted by Genny kim on March 21st, 2018
Human Growth Hormone Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Human Growth Hormone Drugs for these regions, from 2013 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
Request a Sample of Human Growth Hormone Drugs Market Research Report
EMEA Human Growth Hormone Drugs market competition by top manufacturers/players, with Human Growth Hormone Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope - the Somatropin Biosimilar
Somatropin Biopartners
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
If you have any special requirements, please let us know and we will offer you the report as you want.
Table Of Content
EMEA (Europe, Middle East and Africa) Human Growth Hormone Drugs Market Report 2018
1 Human Growth Hormone Drugs Overview
1.1 Product Overview and Scope of Human Growth Hormone Drugs
1.2 Classification of Human Growth Hormone Drugs
1.2.1 EMEA Human Growth Hormone Drugs Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 EMEA Human Growth Hormone Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Norditropin
1.2.4 Genotropin
1.2.5 Humatrope
1.2.6 Saizen
1.2.7 Omnitrope - the Somatropin Biosimilar
1.2.8 Somatropin Biopartners
1.3 EMEA Human Growth Hormone Drugs Market by Application/End Users
1.3.1 EMEA Human Growth Hormone Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Prader-Willi Syndrome
1.3.3 Turner Syndrome
1.3.4 Short Stature Homeobox Gene
1.3.5 Small for Gestational Age
1.3.6 Chronic Renal Insufficiency
1.3.7 Short Bowel Syndrome
1.4 EMEA Human Growth Hormone Drugs Market by Region
1.4.1 EMEA Human Growth Hormone Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 Europe Status and Prospect (2013-2025)
1.4.3 Middle East Status and Prospect (2013-2025)
1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Human Growth Hormone Drugs (2013-2025)
1.5.1 EMEA Human Growth Hormone Drugs Sales and Growth Rate (2013-2025)
1.5.2 EMEA Human Growth Hormone Drugs Revenue and Growth Rate (2013-2025) See More
About Us:
Reports And Markets is part of the Algoro Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer standard global, regional or country specific market research studies for almost every market you can imagine.
Contact Us:
Sanjay Jain
Manager - Partner Relations & International Marketing
www.reportsandmarkets.com
info@reportsandmarkets.com
Ph: +44-020-3286-9338 (UK)
Ph: +1-214-377-1121 (US)
Ph: +91-703-049-0292 (IND)
